Contact Molecules for Homologous Proteins | ||||
![]() [Full Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [SupCon3D] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
31681 | 805 | 379 | Q9BYF1(ACE2_HUMAN) | RecName: Full=Angiotensin-converting enzyme 2; EC=3.4.17.23 ;AltName: Full=Angiotensin-converting enzyme homolog ; Short=ACEH ;AltName: Full=Angiotensin-converting enzyme-related carboxypeptidase ; Short=ACE-related carboxypeptidase; EC=3.4.17.- ;AltName: Full=Metalloprotease MPROT15 ;Contains: RecName: Full=Processed angiotensin-converting enzyme 2 ;Flags: Precursor; |
QUERYSEQ |
MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTL PFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNK NSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVSIWLIVFGVVM GVIVVGIVILIFTGIRDRKKKNKARSGENPYASIDISKGENNPGFQNTDDVQTSF |
805 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() ![]() |
1-17 | SIGNAL | |
![]() ![]() |
18-805 | CHAIN | /note="Angiotensin-converting enzyme 2" /id="PRO_0000028570" |
![]() ![]() ![]() |
18-708 | CHAIN | /note="Processed angiotensin-converting enzyme 2" /id="PRO_0000292268" |
![]() ![]() ![]() |
18-740 | TOPO_DOM | /note="Extracellular" |
![]() ![]() ![]() |
741-761 | TRANSMEM | /note="Helical" |
![]() ![]() |
762-805 | TOPO_DOM | /note="Cytoplasmic" |
![]() ![]() ![]() |
19-607 | DOMAIN | /note="Peptidase M2" |
![]() ![]() |
614-805 | DOMAIN | /note="Collectrin-like" |
![]() ![]() ![]() |
30-41 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" |
![]() ![]() ![]() |
82-84 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" |
![]() ![]() ![]() |
353-357 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" |
![]() ![]() ![]() |
652-659 | REGION | /note="Essential for cleavage by ADAM17" |
![]() ![]() ![]() |
697-716 | REGION | /note="Essential for cleavage by TMPRSS11D and TMPRSS2" |
![]() ![]() |
772-805 | REGION | /note="Disordered" |
![]() ![]() |
785-805 | COMPBIAS | /note="Polar residues" |
![]() ![]() ![]() |
375-375 | ACT_SITE | /note="Proton acceptor" ECO:0000305|PubMed:14754895, ECO:0000305|PubMed:27217402" |
![]() ![]() ![]() |
505-505 | ACT_SITE | /note="Proton donor" ECO:0000305|PubMed:14754895" |
![]() ![]() ![]() |
169-169 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" |
![]() ![]() ![]() |
273-273 | BINDING | /ligand="substrate" |
![]() ![]() ![]() |
345-346 | BINDING | /ligand="substrate" |
![]() ![]() ![]() |
374-374 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" |
![]() ![]() ![]() |
378-378 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" |
![]() ![]() ![]() |
402-402 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" |
![]() ![]() ![]() |
477-477 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" |
![]() ![]() ![]() |
481-481 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" |
![]() ![]() ![]() |
515-515 | BINDING | /ligand="substrate" |
![]() ![]() ![]() |
1-805 | DISORDER | predicted by DISOPRED |
![]() |
|||||||
805 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 100.0 | ACE2_HUMAN Angiotensin-converting enzyme 2 | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
805 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() |
![]() |
B | disordered segment of collectrin homology domain[6.. | A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | disordered segment of collectrin homology domain[2.. | A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | disordered segment of collectrin homology domain[1.. | A | 100.0 /100.0 |
3 /3 |
angiotensin I converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_CVHNL Spike glycoprotein[110 aa] | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_CVHSA Spike glycoprotein[1057 aa] | D | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(.. | B | 100.0 /100.0 |
24 /24 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(.. | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 Spike glycoprotein[643 aa] | A | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[1080 aa] | D | 100.0 /100.0 |
15 /15 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SPIKE_SARS2 Spike glycoprotein[1007 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[1058 aa] | C | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 Spike protein S1[144 aa] | A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | A0A6G6A1M4_9BETC Spike protein S1[194 aa] | A | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | A0A6B9WHD3_SARS Spike glycoprotein[195 aa] | A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | A0A6B9WHD3_SARS Spike glycoprotein[193 aa] | A | 100.0 /100.0 |
13 /13 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | h11B11-Fab[208 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | h11B11-Fab[210 aa] | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | h11B11-Fab[210 aa] | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[201 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[194 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1[198 aa] | B | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[193 aa] | B | 100.0 /100.0 |
15 /15 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 3E8[223 aa] | B | 100.0 /100.0 |
12 /12 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 3E8[214 aa] | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RshSTT182/200 coronavirus receptor binding domain .. | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | S6A20_HUMAN Sodium- and chloride-dependent transporter XTRP3[5.. | B | 100.0 /100.0 |
19 /19 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR.. | A | 100.0 /100.0 |
34 /34 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR.. | A | 100.0 /100.0 |
33 /33 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR.. | A | 100.0 /100.0 |
33 /33 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 05B04 Heavy Chain[218 aa] | A | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() |
![]() |
C | 05B04 Light Chain[214 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | SPIKE_SARS2 Spike protein S1[162 aa] | C | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 Spike protein S1[167 aa] | A | 100.0 /100.0 |
13 /13 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Peptide 1[13 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Peptide 2[15 aa] | A | 100.0 /100.0 |
25 /25 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Peptide 6[12 aa] | A | 100.0 /100.0 |
19 /19 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 Spike protein S1[195 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1[183 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_CVHSA SARS-coronavirus spike protein[174 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_CVHSA SPIKE_SARS2 SPIKE_CVHSA SARS-CoV-2 chimeric RBD[193 aa] | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
805 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NAG
|
A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NAG
|
A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
NAG
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
NAG
|
B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
NAG
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NAG
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
GB |
NAG
|
D | 100.0 /100.0 |
2 /2 |
Angiotensin-converting enzyme 2 (ACE2) ectodomain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
NAG
|
A | 100.0 /99.8 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NAG
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IB |
NAG
|
D | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
KB |
NAG
|
D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LB |
NAG
|
D | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NAG
|
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
XX5
|
A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN angiotensin I converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
W |
3PH
|
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
LFI
|
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
LFI
|
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
NDG
|
A | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
NDG
|
B | 100.0 /98.5 |
1 /1 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
NDG
|
B | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
805 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
ZN
|
A | 100.0 /100.0 |
4 /4 |
angiotensin I converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
ZN
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
ZN
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
ZN
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
ZN
|
B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ZN
|
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
BB |
NA
|
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
YA |
NA
|
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
NA
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NA
|
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
MG
|
B | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
CL
|
A | 100.0 /100.0 |
4 /4 |
angiotensin I converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
FB |
CL
|
I | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
GB |
CL
|
I | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AB |
CL
|
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CB |
CL
|
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DB |
CL
|
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EB |
CL
|
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
XA |
CL
|
J | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
CL
|
E | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
CL
|
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
CL
|
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
CL
|
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CL
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
AC |
CL
|
E | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
SA |
CL
|
E | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
TA |
CL
|
E | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
VA |
CL
|
E | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
JB |
CL
|
F | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LB |
CL
|
F | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
805 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
EA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /98.8 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /98.8 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
R | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
U | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
GA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-bet.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /98.8 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | C | 100.0 /98.8 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | D | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /99.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. | A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alp.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. | B | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | C | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | A | 100.0 /98.8 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | A | 100.0 /99.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 85.7 /96.1 |
7 /7 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1.. | A | 100.0 /96.1 |
13 /13 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /95.8 |
3 /3 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /95.8 |
15 /15 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
805 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() |
![]() |
B | ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] | A | 100.0 /98.5 |
2 /2 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] | B | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | ACE2_HUMAN Angiotensin-converting enzyme 2[593 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | ACE2_HUMAN Angiotensin-converting enzyme 2[748 aa] | B | 100.0 /100.0 |
26 /26 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ACE2_HUMAN Angiotensin-converting enzyme 2[711 aa] | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ACE2_HUMAN Processed angiotensin-converting enzyme 2[591 aa] | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ACE2_HUMAN Angiotensin-converting enzyme 2[749 aa] | A | 100.0 /100.0 |
22 /22 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
805 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PA |
PGE
|
I | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
PGE
|
A | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
TRS
|
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
PEG
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
PEG
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
GOL
|
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
GOL
|
A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
A | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
GOL
|
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 100.0 /98.8 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /99.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EDO
|
B | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
EDO
|
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /95.8 |
2 /2 |
Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA |
EDO
|
E | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
OA |
EDO
|
E | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PA |
EDO
|
E | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
QA |
EDO
|
E | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
B | 100.0 /95.8 |
3 /3 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |